Synergy CHC Corp. Restricted Cash and Cash Equivalents
Synergy CHC Corp. (SNYR) had Restricted Cash and Cash Equivalents of $100.00 thousand as of 2020-03-31, per its 10-Q filed 2020-06-29.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-06-29
- 2020-03-31: Restricted Cash and Cash Equivalents $100.00K.
- 2019-12-31: Restricted Cash and Cash Equivalents $100.00K.
- 2019-09-30: Restricted Cash and Cash Equivalents $100.00K.
- 2019-06-30: Restricted Cash and Cash Equivalents $136.97K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-03-31 | $100.00K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $100.00K 10-Q · filed 2020-06-29 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $136.97K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $137.35K 10-Q · filed 2020-06-29 |
| 2018-12-31 | $136.18K 10-K · filed 2020-04-29 |
| 2018-09-30 | $137.10K 10-Q · filed 2019-11-14 |
| 2018-06-30 | $138.02K 10-Q · filed 2019-08-13 |
| 2018-03-31 | $139.44K 10-Q · filed 2019-05-03 |
| 2017-12-31 | $139.07K 10-K · filed 2019-03-29 |
| 2017-09-30 | $139.17K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $138.38K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $138.19K 10-Q · filed 2017-05-01 |
| 2016-12-31 | $100.00K 10-K · filed 2018-04-02 |
| 2016-09-30 | $291.62K 10-Q · filed 2016-10-26 |
| 2016-06-30 | $291.62K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $158.14K 10-Q · filed 2016-04-25 |
| 2015-12-31 | $607.08K 10-K · filed 2017-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |